ALFA Filings
Every announcement, straight from the exchange
Every Infinium Pharmachem other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
Infinium Pharmachem Limited filed its quarterly SEBI Regulation 74(5) compliance certificate for the period ending September 30, 2026, confirming all shares are held in demat form.
Infinium Pharmachem Limited has appointed an Internal Auditor, Secretarial Auditor, and Cost Auditor for the Financial Year 2026-27 to comply with statutory regulatory requirements.
Infinium Pharmachem Limited submitted a compliance certificate confirming that all shares remain in dematerialised form. No rematerialisation requests were received for the quarter ended March 31, 2026. This is a routine regulatory update with no material impact on business operations or financials.